27th May 2011
Omega-3 fatty acids may reduce the risk of heart problems for patients with stents in their arms, according to new research.
A study conducted at Jagiellonian University in Krakow, Poland and detailed in the journal Arteriosclerosis, Thrombosis and Vascular Biology highlighted that when combined with two blood-thinning drugs, omega-3 can make significant changes to the blood clotting process.
Over the course of the research, patients were given omega-3 in pill form and also encouraged to up their intake of oily fish, as well as taking both aspirin and clopidogrel.
It was noted that the patients who had taken the omega-3 had blood clots which were more susceptible to destruction than the placebo group and also demonstrated less oxidative stress.
Commenting, the study's lead author Dr Grzegorz Gajos said: "Our study suggests that combined moderate anti-thrombotic and anti-platelet actions of omega-3, when added to those of other treatments, may improve outcomes for coronary artery disease patients."
According to the British Heart Foundation, around one million men and nearly 500,000 women have heart disease in the UK.
Posted by Jeanette Royston
1. Grzegorz Gajos, Jaroslaw Zalewski, Pawel Rostoff, Jadwiga Nessler, Wieslawa Piwowarska, and Anetta Undas.Reduced Thrombin Formation and Altered Fibrin Clot Properties Induced by Polyunsaturated Omega-3 Fatty Acids on Top of Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Intervention. Arteriosclerosis, Thrombosis and Vascular Biology: Journal of the American Heart Association, 2011.
Health News is provided by Adfero in collaboration with Spire Healthcare. Please note that all copy above is ©Adfero Ltd. and does not reflect views or opinions of Spire Healthcare unless explicitly stated. Additional comments on the page from individual Spire consultants do not necessarily reflect the views or opinions of other consultants or Spire Healthcare.